ACTRN12609001066279已完成2 期
Inhaled mannitol for the treatment of mucociliary dysfunction in patients with asthma - Its effect and mechanisms on the clearance of mucus
Dr Evangelia Daviskas0 个研究点目标入组 10 人开始时间: 2009年12月11日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 17 Years 至 o limit（—）
- 性别
- All
入选标准
- •chronic cough and sputum production
排除标准
- •fall in FEV1 greater or equal to 15% in response to mannitol
- •bronchiectasis based on high resolution computed tomography (HRCT)
研究者
相似试验
进行中（未招募）
1 期
ong Term Administration of Inhaled Mannitol in Cystic Fibrosis – A Safety and Efficacy Trial in Adult Cystic Fibrosis SubjectsCystic FibrosisMedDRA version: 18.0Level: LLTClassification code 10011764Term: Cystic fibrosis NOSSystem Organ Class: 100000004850EUCTR2013-005357-79-HUPharmaxis Limited440
进行中（未招募）
1 期
ong Term Administration of Inhaled Mannitol in Cystic Fibrosis – A Safety and Efficacy Trial in Adult Cystic Fibrosis SubjectsCystic FibrosisEUCTR2013-005357-79-SKPHARMAXIS LTD440
进行中（未招募）
1 期
ong Term Administration of Inhaled Mannitol in Cystic Fibrosis – A Safety and Efficacy Trial in Adult Cystic Fibrosis SubjectsCystic FibrosisEUCTR2013-005357-79-GRPharmaxis Limited440
进行中（未招募）
1 期
ong Term Administration of Inhaled Mannitol in Cystic Fibrosis – A Safety and Efficacy Trial in Adult Cystic Fibrosis SubjectsMedDRA version: 17.0Level: LLTClassification code 10011764Term: Cystic fibrosis NOSSystem Organ Class: 100000004850Cystic FibrosisEUCTR2013-005357-79-ITPharmaxis Limited423
进行中（未招募）
1 期
ong Term Administration of Inhaled Mannitol in Cystic Fibrosis – A Safety and Efficacy Trial in Adult Cystic Fibrosis SubjectsMedDRA version: 19.0Level: LLTClassification code 10011764Term: Cystic fibrosis NOSSystem Organ Class: 100000004850Cystic FibrosisEUCTR2013-005357-79-CZPharmaxis Limited440